NEW INJECTABLE DRUG TREATS MODERATE-TO-SEVERE PLAQUE PSORIASIS

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD 21201 USA
来源：
AMERICAN JOURNAL OF NURSING | 2017年 / 117卷 / 06期
关键词：
D O I：
10.1097/01.NAJ.0000520249.90632.58
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Drug survival of secukinumab for moderate-to-severe plaque psoriasis
    Lee, E. B.
    Reynolds, K. A.
    Pithadia, D. J.
    Wu, J. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 222 - 222
  • [2] Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis
    Egeberg, Alexander
    Bryld, Lars Erik
    Skov, Lone
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 173 - 178
  • [3] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [4] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [5] A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast
    Chiricozzi, Andrea
    Caposiena, Dante
    Garofalo, Virginia
    Cannizzaro, Maria Vittoria
    Chimenti, Sergio
    Saraceno, Rosita
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (03) : 237 - 249
  • [6] Comment on "Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis"
    Lebwohl, Mark G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E377 - E377
  • [7] Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis
    Frampton, James E.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 295 - 306
  • [8] The management of moderate-to-severe chronic plaque psoriasis
    Tonini, Annalisa
    Panduri, Salvatore
    D'Erme, Angelo M.
    Papadia, Francesca
    Romaneli, Marco
    Krueger, James G.
    Chiricozzi, Andrea
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (05): : 447 - 457
  • [9] Advances in the treatment of moderate-to-severe plaque psoriasis
    Herrier, Richard N.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (09) : 795 - 806
  • [10] Guselkumab for the treatment of moderate-to-severe plaque psoriasis
    Yang, Eric J.
    Sanchez, Isabelle M.
    Beck, Kristen
    Sekhon, Sahil
    Wu, Jashin J.
    Bhutani, Tina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 333 - 344
12345